Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06360822

Increasing Equity in Lung Cancer Screening

The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eskenazi Health

Indianapolis, Indiana, 46202, United States

Location status: Recruiting

Location contact

Nicholas Pettit, MD

CONTACT

[email protected]

317-962-5975

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years)

Exclusion criteria

  • • Non-English/Spanish speaking
  • Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment
  • Intoxicated with alcohol or drugs
  • Cannot provide reliable follow up contact information (cell phone)
  • Presenting to the ED with a life-threatening condition
  • Have received chest CT scan in past 12 months
  • Already enrolled in LCS
  • Hospice enrolled

Treatment and study plan

ED-LCS

Behavioral

This is a lung cancer educational intervention for patients in the emergency department.

Primary outcomes

  1. Rate of patients receive Lung Cancer Screening

    Time frame: 6-12 months

Secondary outcomes

  1. Patients ratings of intervention

    Time frame: At delivery

    This is a subjective rating provided by patients of the intervention received

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

  • Eskenazi Health

Registry information

Acronym: LUCARE

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Apr 11, 2024
Registry last updated
Aug 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.